Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000912057-19-000136
Filing Date
2019-04-01
Accepted
2019-04-01 17:04:21
Documents
28

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1892142
2 filename2.htm EX-10.4 613446
3 g33872ma09i001.gif GRAPHIC 38279
4 g33872ma13i001.jpg GRAPHIC 34448
5 g33872ma13i002.jpg GRAPHIC 63207
6 g33872ma15i001.gif GRAPHIC 73022
7 g33872ma15i002.gif GRAPHIC 27769
8 g57012.jpg GRAPHIC 94475
9 g79071.jpg GRAPHIC 19902
10 g162259.jpg GRAPHIC 17342
11 g195482.jpg GRAPHIC 95774
12 g212626.jpg GRAPHIC 49639
13 g248496.jpg GRAPHIC 31326
14 g296577.jpg GRAPHIC 40676
15 g308280.jpg GRAPHIC 100900
16 g333345.jpg GRAPHIC 39340
17 g361630.jpg GRAPHIC 32143
18 g449255.jpg GRAPHIC 137483
19 g454639.jpg GRAPHIC 125099
20 g505554.jpg GRAPHIC 170902
21 g634913.jpg GRAPHIC 36588
22 g748691.jpg GRAPHIC 127696
23 g767357.jpg GRAPHIC 94125
24 g809974.jpg GRAPHIC 19828
25 g831763.jpg GRAPHIC 21727
26 g859618.jpg GRAPHIC 53195
27 g902545.jpg GRAPHIC 52093
28 g988525.jpg GRAPHIC 49526
  Complete submission text file 0000912057-19-000136.txt   4775558
Mailing Address 13503 SANDERLING PLACE GERMANTOWN MD 20874
Business Address 13503 SANDERLING PLACE GERMANTOWN MD 20874 240-418-1773
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-02478 | Film No.: 19721614
SIC: 2834 Pharmaceutical Preparations